The National Center for Advancing Translational Sciences (NCATS) has developed Inxight: Drugs as a comprehensive portal for drug development information. NCATS Inxight: Drugs contains information on ingredients in medicinal products, including:

US Approved Drugs: 2932

Marketed Drugs: 6045

Investigational Drugs: 6957

All Substances: 102012

NCATS Inxight: Drugs incorporates and unifies a wealth of data, including manually curated data supplied by the FDA and private companies, and provides marketing and regulatory status, rigorous drug ingredient definitions, biological activity, clinical use, and more.

NCATS has developed Inxight data resources to facilitate translational research. All facts appearing in these datasets are in the public domain and may be reproduced or copied without NCATS permission. Citation of the source is appreciated.

Please note that these datasets are continually updated and refreshed, and users are encouraged to update derivative works frequently.

A supplementary resource — Novel FDA Drug Approvals — features new molecules approved by the FDA by year. Comprehensive data are provided for 2018, with additional data available since 2012. Each molecule has a summary, clinical development timeline, and details about the review process used by the FDA to approve the drug.